CURIS, INC. Additional Paid in Capital, Common Stock
CURIS, INC. (CRIS) had Additional Paid in Capital, Common Stock of $1.28 billion as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-14
- 2026-06-30: Additional Paid in Capital, Common Stock $1.28B.
- 2026-03-31: Additional Paid in Capital, Common Stock $1.28B.
- 2025-12-31: Additional Paid in Capital, Common Stock $1.25B; Additional Paid in Capital, Common Stock as first filed $1.25B.
- 2025-09-30: Additional Paid in Capital, Common Stock $1.25B.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $1.28B 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.28B 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.25B 10-Q · filed 2026-08-14 | $1.25B 10-K · filed 2026-03-24 |
| 2025-09-30 | $1.25B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.24B 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $1.24B 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.23B 10-K · filed 2026-03-24 | |
| 2024-09-30 | $1.22B 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.22B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $1.22B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.22B 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.21B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.20B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.20B 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $1.20B 10-K · filed 2024-02-08 | $1.19B 10-K · filed 2023-03-13 |
| 2022-09-30 | $1.19B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.19B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.18B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.18B 10-K · filed 2023-03-13 | |
| 2021-09-30 | $1.18B 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.18B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $1.18B 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $1.18B 10-K · filed 2022-02-24 | |
| 2020-09-30 | $1.01B 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $1.00B 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $986.05M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $982.74M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $982.02M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $981.34M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $980.66M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $980.01M 10-K · filed 2020-03-19 | |
| 2018-09-30 | $979.35M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $978.46M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $975.83M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $977.45M 10-K · filed 2019-03-26 | $976.13M 10-K · filed 2018-03-08 |
| 2017-09-30 | $974.56M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $938.08M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $936.25M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $928.32M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $925.57M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $905.61M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $904.08M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $903.24M 10-K · filed 2017-03-09 | $903.24M 10-K · filed 2016-02-29 |
| 2015-09-30 | $901.24M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $900.34M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $899.25M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $810.00M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |